Researchers from the University of Texas MD Anderson Cancer Center in Houston have found the cost of treating people with hepatitis C virus with newly approved therapies may cost the country’s health ...

Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). Experts estimate that about 2.4 million people in the United States are living with hepatitis C—but that figure could be ...

(Reuters) - The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover ...

SAN FRANCISCO — Medicaid programs in Delaware, Maryland, New Jersey, and Pennsylvania denied nearly half of all claims in recent months for direct-acting antiviral hepatitis C drugs, according to an ...

Louisiana is communicating with CMS to explore a subscription-based payment model for hepatitis C treatments, according to a proposal the Louisiana Department of Health released this week. The health ...

Understanding what hepatitis C is, how it spreads and how it is treated can replace fear with clarity.

New Haven drug developer Achillion Pharmaceuticals Inc. has launched its first human trial of one of its treatment for chronic hepatitis C. The company says the double-blind Phase 1 study of its ...

NEW YORK (Reuters) - A hepatitis C treatment being developed by Vertex Pharmaceuticals Inc led to a 75 percent cure rate in a pivotal trial of previously untreated patients, the company said on ...

A new report questions the safety of some of the new drugs found to cure hepatitis C, in light of findings of liver failure and injury. But hepatitis C virus (HCV) experts say the findings are ...